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ABSTRACT: Prazosin is an alpha 1 adrenoceptor antagonist, and it is used as an 
antihypertensive agent. The effects of prazosin on the activity of hepatic triacylglycerole 
lipase (HTGL) are not fully understood. In this study, we demonstrated that prazosin 
stimulates the release of HTGL activity from primary cultures of rat hepatocytes in a time- 
and dose- dependent manner. U-73122, a phopholipase C (PLC) inhibitor, suppresses 
prazosin’s stimulation of the release of HTGL activity. Moreover, prazosin stimulated 
the increase of PLC activity in the hepatocytes in a time- and dose- dependent manner. In 
addition, the prazosin-stimulated release of HTGL activity was reduced by Quin2/AM (an 
intracellular Ca2+-chelator), W-7 (a Calmodulin inhibitor), and KN-93 (an inhibitor of Ca2+/
Calmodulin dependent protein kinase (CaMK)–II). These results suggest that the prazosin-
stimulated release of HTGL activity is partly due to the activation of CaMK-II that is 




は、ホスホリパーゼ C（PLC）阻害剤により抑制された。さらに肝細胞内の PLC 活性
は、プラゾシンにより促進された。加えて、Ca2+ キレーター、カルモジュリン阻害剤、
Ca2+/ カルモジュリン依存性プロテインキナーゼⅡ（CaMK-II）阻害剤により HTGL の
活性は抑制された。これらの結果、プラゾシンによる HTGL の分泌促進は、肝細胞内
で PLC 活性の上昇と共に CaMK-II の活性化が関与していることが示唆された。
